• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD INSULIN PUMP; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD INSULIN PUMP; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 14000
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Hyperglycemia (1905); Myocardial Infarction (1969); Vomiting (2144); Elevated ketones/Diabetic Ketoacidosis (2364); Ambulation or Postural Difficulties (2544)
Date of Event 05/12/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that the patient had been hospitalized with diabetic ketoacidosis (dka) on (b)(6) 2026.The patient's blood glucose levels reached over 400 mg/dl.It was noted that the insulin from the pod was froze due to keeping it in a refrigerator while camping, causing the patient¿s blood glucose to rise.Symptoms reported include vomiting, chest pressure, and trouble walking.The patient was treated with intravenous (iv) fluids and insulin drip.The patient was discharged on (b)(6) 2026.
 
Additional Manufacturer Narrative
The device has not been returned/received to date.If the device is received, a supplemental report will be submitted with the investigation results.We are unable to determine if any product condition could have contributed to the reported event.No lot release records were reviewed, as the product lot number was not provided.High blood glucose is a common symptom for people with diabetes (glucose monitoring data from people with diabetes indicate that on average, they can experience blood glucose levels above 250 mg/dl for 14-25% of the time[1][2][3]), and it would be challenging to speculate on a cause for the complaints without receiving the devices back for an engineering investigation.[1] beck rw, bergenstal rm, cheng p, kollman c, carlson al, johnson ml, rodbard d.The relationships between time in range, hyperglycemia metrics, and hba1c.J diabetes sci technol 2019;13:614-626.[2] welsh jb, derdzinski m, parker as, puhr s, jimenez a, walker t.Real-time sharing and following of continuous glucose monitoring data in youth.Diabetes ther 2019;10:751-755.[3] puhr s, derdzinski m, welsh jb, parker as, walker t, price da.Real-world hypoglycemia avoidance with a continuous glucose monitoring system's predictive low glucose alert.Diabetes technol ther 2019;21:155-158.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD INSULIN PUMP
Common Device Name
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
derek heyl
100 nagog park
acton, MA 01720
9786007000
MDR Report Key25451736
Report Number3014585508-2026-34202
Device Sequence Number18728828
Product Code LZG
UDI-Device Identifier20385081120002
UDI-Public(01)20385081120002(10)UNAVAILABLE
Combination Product (Y/N)N
PMA/510(K) Number
K122953
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 06/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number14000
Device Catalogue NumberZXP425
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/19/2026
Initial Report FDA Received Date06/09/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age65 YR
Patient SexFemale
-
-